Search

everythinglearnresearchcommunity

for

Search:↓

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

CS12192 effectively treats alopecia areata with better safety than current options.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Biological therapy boosts the immune system to effectively fight melanoma.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

A chimeric keratin partially improved skin structure in mice lacking keratin 5, but didn't fully restore normal skin.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

The research developed new fortilin protein constructs for potential heart disease treatments.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Blocking LFA-1 prevents hair loss in mice.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

A patient developed a blister at the injection site after hepatitis C treatment.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Genetically modified cells improved skin wound healing in rats.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The developed system could effectively treat hair loss and promote hair growth.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

The PML protein helps prevent skin cancer in mice.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.